Back
Arcturus Therapeutics Holdings Quote, Financials, Valuation and Earnings
Buy
61
ARCT
Arcturus Therapeutics Holdings
Last Price:
29.78
Seasonality Move:
25.77%
7 Day Trial
ALL ACCESS PASS
$
7
Arcturus Therapeutics Holdings Price Quote
$29.78
Arcturus Therapeutics Holdings Key Stats
Buy
61
Arcturus Therapeutics Holdings (ARCT)
is a Buy
Day range:
$29.58 - $30.59
52-week range:
$17.52 - $43.81
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.19
P/B ratio:
3.04%
Volume:
354.6K
Avg. volume:
496.1K
1-year change:
5.16%
Market cap:
$802M
Revenue:
$157.7M
EPS:
$-3.91
How Much Does Arcturus Therapeutics Holdings Make?
-
How Much Are Arcturus Therapeutics Holdings's Sales Annually?
ARCT Revenues are $157.7M -
How Much Profit Does Arcturus Therapeutics Holdings's Make A Year?
ARCT net income is -$29.7M
Is Arcturus Therapeutics Holdings Growing As A Company?
-
What Is Arcturus Therapeutics Holdings's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.59% -
What Is Arcturus Therapeutics Holdings's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Arcturus Therapeutics Holdings Stock Price Performance
-
Did Arcturus Therapeutics Holdings Stock Go Up Last Month?
Arcturus Therapeutics Holdings share price went up by 7.74% last month -
Did ARCT's Share Price Rise Over The Last Year?
ARCT share price rose by 5.16% over the past 1 year
What Is Arcturus Therapeutics Holdings 52-Week High & Low?
-
What Is Arcturus Therapeutics Holdings’s 52-Week High Share Price?
Arcturus Therapeutics Holdings has traded as high as $43.81 over the past 52 weeks -
What Is Arcturus Therapeutics Holdings’s 52-Week Low Share Price?
Arcturus Therapeutics Holdings has traded as low as $17.52 over the past 52 weeks
Arcturus Therapeutics Holdings Price To Free Cash Flow
-
Is Arcturus Therapeutics Holdings Stock Overvalued?
Arcturus Therapeutics Holdings is trading at a price to free cash flow ratio of 81.47 -
Is Arcturus Therapeutics Holdings Stock Undervalued?
Arcturus Therapeutics Holdings EV to Free Cash Flow ratio is 52.60 -
What Is Arcturus Therapeutics Holdings’s Price Earnings Growth Ratio?
ARCT PEG ratio is 0.00 -
Is Arcturus Therapeutics Holdings Trading At A Premium To Earnings?
Arcturus Therapeutics Holdings EV to EBIT ratio is 0.00
Is It Risky To Buy Arcturus Therapeutics Holdings?
-
How Much Debt Does Arcturus Therapeutics Holdings Have?
Total long term debt quarterly is $0 -
How Much Cash Does Arcturus Therapeutics Holdings Have?
Cash and short term investments quarterly total is $288.4M -
What Is Arcturus Therapeutics Holdings’s Book Value Per Share?
Book value per share is 9.81
Is Arcturus Therapeutics Holdings Cash Flow Positive?
-
What Is ARCT Cash Flow From Operations?
Cash flow from operations (TTM) is $12.2M -
What Is Arcturus Therapeutics Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is $5.5M -
What Is Arcturus Therapeutics Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$2.5M
Arcturus Therapeutics Holdings Return On Invested Capital
-
Is Management Doing A Good Job?
ARCT return on invested capital is -36.82% -
What Is Arcturus Therapeutics Holdings Return On Assets?
ROA measures how assets are converting to revenues and is -24.3% -
What Is ARCT Return On Equity?
ROE is a measure of profitability and is -37.33%
Arcturus Therapeutics Holdings Earnings Date & Stock Price
-
What Is Arcturus Therapeutics Holdings's Stock Price Today?
A single share of ARCT can be purchased today for 29.78 -
What Is Arcturus Therapeutics Holdings’s Stock Symbol?
Arcturus Therapeutics Holdings trades on the nasdaq under the ticker symbol: ARCT -
When Is Arcturus Therapeutics Holdings’s Next Earnings Date?
The next quarterly earnings date for Arcturus Therapeutics Holdings is scheduled on August 7, 2024 -
When Is ARCT's next ex-dividend date?
Arcturus Therapeutics Holdings's next ex-dividend date is May 15, 2020 -
How To Buy Arcturus Therapeutics Holdings Stock?
You can buy Arcturus Therapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Arcturus Therapeutics Holdings Competitors
-
Who Are Arcturus Therapeutics Holdings's Competitors?
Below is a list of companies who compete with Arcturus Therapeutics Holdings or are related in some way:
Arcturus Therapeutics Holdings Dividend Yield
Data Unavailable
Arcturus Therapeutics Holdings Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 12.59% |
| Revenue: | -59.11% | 115.09% |
Analyst Recommendations
| Buy Recommendations: | 6 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 72.29 |
| Upside from Last Price: | 142.76% |